Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Department of Veterans Affairs |
---|---|
Information provided by: | Department of Veterans Affairs |
ClinicalTrials.gov Identifier: | NCT00108342 |
The purpose of this study is to see how people like the nicotine medications and to see if the treatment given helps people quit smoking.
Hypothesis: Combining nicotine reduction therapies, tailoring treatment and adding training can significantly reduce early drop-out and slips responsible for relapse and low outcome rates in smoking cessation.
Condition | Intervention | Phase |
---|---|---|
Smoking |
Drug: patch Drug: nasal spray Drug: inhaler Drug: gum |
Phase I |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Uncontrolled, Parallel Assignment, Efficacy Study |
Official Title: | Nicotine Delivery Systems: Research and Treatment |
Ages Eligible for Study: | 25 Years to 55 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | ADRD-020-02S |
Study First Received: | April 14, 2005 |
Last Updated: | March 27, 2008 |
ClinicalTrials.gov Identifier: | NCT00108342 |
Health Authority: | United States: Federal Government |
Smoking Cessation drug therapy behavior therapy |
Nicotine polacrilex Smoking Nicotine |
Habits |